Key Points AFFO per share (non-GAAP) was $0.38, beating consensus by $0.35 (non-GAAP) and AFFO per share soared to $0.38, beating consensus by $0.35 and representing a 22% year-over-year increase. Net ...

Key Financial and Operational Developments Zimmer Biomet delivered GAAP revenue of $2.077 billion, beating analysts' expectations on a non-GAAP basis. Growth was especially strong in the S.E.T.

Below are the transcripts from the Q2 earnings call, which took place Thursday morning. This transcript is brought to you by ...

Discover key insights from NCR Voyix's Q2 2025 earnings call, including growth in recurring revenue, software ARR, and payments integration.

Q2 2025 Management View CEO Olivier Pomel stated that "overall, we saw trends for usage growth from existing customers in Q2 ...